Shanghai Allist Pharmaceuticals stock: dividend
688578.SSShanghai Allist Pharmaceuticals paid $0.18 per share over the last twelve months, 1.44% on the price, and has not cut its dividend for 2 years.
Daily figure as of 13 Nov 2026
The amounts for the last 12 months and for fiscal 2025 differ if the company has raised or cut its dividend since then.
The dividend is covered by earnings (payout ratio 21%) but not by free cash flow. The stock page lists a weakness only when neither covers it.
Dividend dates and payments
Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.
All 6 payments of the last five years
| Ex-dividend date | Payment date | Dividend per share |
|---|---|---|
| 2 Sep 2026 | 2 Sep 2026 | $0.0900 |
| 1 Jun 2026 | 1 Jun 2026 | $0.0900 |
| 10 Sep 2025 | 10 Sep 2025 | $0.0600 |
| 3 Jun 2025 | 3 Jun 2025 | $0.0600 |
| 5 Sep 2024 | 5 Sep 2024 | $0.0375 |
| 31 May 2024 | 31 May 2024 | $0.0600 |
Is today's dividend yield unusually high?
Dividend yield today
1.44%
$0.18 dividend per share over the last twelve months on a price of $12.46
Today 1.44%, on average over fiscal years 2020 to 2025 0.96% (range 0.01 to 1.09%). That is higher than in each of the 3 fiscal years with a recorded dividend.
Since the end of fiscal 2025 on 31 Dec 2025, the dividend has risen and the price has fallen, so the yield has risen, because of both.
- Fiscal year
- Today, last 12 months
For each fiscal year, the dividend per share for that year divided by the closing price on the last trading day of the fiscal year. The dashed line is the average (median) of the fiscal years.
No dividend is recorded for 2021, 2022, and 2023, either because it was suspended or because the company did not report it. These years do not count towards the average and the range.
Dividend development
Dividend per share
Payout ratio
- of earnings
- of free cash flow
Figures as a table
| Year | Dividend per share | Earnings per share |
|---|---|---|
| 2019 | $0.01385 | −$0.16 |
| 2020 | $0.00048 | −$0.13 |
| 2024 | $0.09748 | $0.48 |
| 2025 | $0.14996 | $0.73 |
The dividend per share is shown under the fiscal year it was paid for, even when it is paid after that year ends. Special dividends are not included.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 9 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.